Please login to the form below

Not currently logged in
Email:
Password:

Intercytex

This page shows the latest Intercytex news and features for those working in and with pharma, biotech and healthcare.

UK regenerative medicine projects get £8.5m boost

An £8.5m package of grants will be shared by 14 projects in development by companies that include Cell Medica, Intercytex and Lonza Biologics. ... The projects will be led by: Altrika, Asymptote, Cell Medica, CellSeed Europe, Cellzome, ImmunoSolv,

Latest news

  • Take off

    Turnover was zero. Intercytex uses the body's own repair mechanisms to slow down ageing. ... Intercytex has a skin replacement product for burns, and is aiming for this to replace skin grafts.

  • Merger mania hits

    The company uses human cells for its skin and hair replacement products - a market that Intercytex believes is worth some $6bn in sales. ... Intercytex currently has a venous leg ulcer treatment in phase III trials and expects to release further

  • Bright backdrop

    On the new listings AIM front, where a wave of biotech and healthcare companies are thought to be putting the final touches to their plans for a flotation, Intercytex, a

  • Up and up?

    Meanwhile, Intercytex, a firm is working on a treatment for baldness, hopes to raise around £15m through a floatation on AIM.

  • Weathering the storm

    Intercytex seeks backing for serious wound product. Intercytex, the speciality pharmaceutical and biotech firm, posted a pre-tax loss of £11.6m on sales up 34 per cent to £111, 000. ... The company's lead product is a treatment for serious wounds and

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....